Eli Lilly Advances Zepbound and Retatrutide Amid Market Speculation | Retatrutide News

Eli Lilly's updates on Zepbound and Retatrutide are drawing market attention. These developments are significant for the company's position in the GLP-1...
Market News · October 10, 2026